If one word could be used to describe the state of healthcare these days, it would have to be “innovation.” From new therapies using gene sequencing to advanced AI-driven medical devices, innovation is what rules the sector. And for the latest pick to our Best Dividend Stocks Model Portfolio, innovation is translating into some blockbuster sales.
Already one of the top drug producers in the world, our pick has spent the last few years building out its advanced portfolio of drugs. The firm is an oncology superstar with some of its top drugs in fighting cancer have realized billions in sales, allowing the firm to plow hefty funds into M&A and research to grow its portfolio and pipeline.
It’s also helped investors in the rewards department. Our pick remains a buyback champion, managing to increase its dividend for 11 years straight. Its latest increase was over 6%. All in all, our pick has plenty of growth left in the tank.
In order to make room for our healthcare stock and another industrial pick, we are forced to drop an asset manager and chemicals producer from our list this week.
You can check out the Best Dividend Stocks Model Portfolio to explore all the stocks.
